Reduction of glycosylated hemoglobin and postprandial hyperglycemia by acarbose in patients with NIDDM. A placebo-controlled dose-comparison study.
about
Alpha-glucosidase inhibitors for type 2 diabetes mellitusD-tagatose, a novel hexose: acute effects on carbohydrate tolerance in subjects with and without type 2 diabetes.Metformin versus acarbose therapy in patients with polycystic ovary syndrome (PCOS): a prospective randomised double-blind study.Glucose supply and insulin demand dynamics of antidiabetic agents.Oral medications for treating diabetes mellitus in dogs and cats.Using dose-response characteristics of therapeutics agents for treatment decisions in type 2 diabetes.Clinical importance of insulin secretion and its interaction with insulin resistance in the treatment of type 2 diabetes mellitus and its complications.Type 2 diabetes therapy. A pathophysiologically based approach.Evaluation of the efficacy and tolerability of miglitol in Chinese patients with type 2 diabetes mellitus inadequately controlled by diet and sulfonylureas.When diet fails: insulin and oral hypoglycemic agents as alternatives for the management of gestational diabetes mellitus.A review of the treatment of type 2 diabetes in childrenEfficacy and safety of prolonged-release melatonin in insomnia patients with diabetes: a randomized, double-blind, crossover studyCan the Glycemic Index (GI) be used as a tool in the prevention and management of Type 2 diabetes?Alpha-glucosidase inhibitors and hepatotoxicity in type 2 diabetes: a systematic review and meta-analysisDietary carbohydrates and cardiovascular disease risk factors in the Framingham offspring cohort.Comparison of acarbose and voglibose in diabetes patients who are inadequately controlled with basal insulin treatment: randomized, parallel, open-label, active-controlled study.Meta-analysis and critical review on the efficacy and safety of alpha glucosidase inhibitors in Asian and non-Asian populations.Stage of change advancement for diabetes self-management behaviors and glucose control.Cinnamon extract inhibits α-glucosidase activity and dampens postprandial glucose excursion in diabetic rats.Inhibitory activity of Euonymus alatus against alpha-glucosidase in vitro and in vivo.Trends in the prescribing of oral agents for the management of type 2 diabetes mellitus in the United States, 1990-2001: does type of insurance influence access to innovation?Hypoglycemic and hypolipidemic effects of Saururus chinensis Baill in streptozotocin-induced diabetic rats.Acarbose: its role in the treatment of diabetes mellitus.Non-insulin dependent diabetes in children and adolescents: the therapeutic challenge.Hypoglycemic effects of Welsh onion in an animal model of diabetes mellitus.Effects of chronic treatment with acarbose on glucose and lipid metabolism in obese diabetic Wistar rats.Towards understanding of glycaemic index and glycaemic load in habitual diet: associations with measures of glycaemia in the Insulin Resistance Atherosclerosis Study.Treatment of familial hypertriglyceridaemia with acarbose.
P2860
Q24246908-88C99053-26C7-408B-BDB5-7C3FA4EB9DDFQ32064660-83D9A096-03AD-41C1-9FC6-58F647A362A6Q33447184-AFD677EE-D352-40BC-99F0-692CF6A470E9Q33828255-A4F70938-56CB-4BA7-8F29-4D4F8FDE4D98Q34098405-44AE5A48-6DCE-469C-AB11-8E4023C7DF01Q34163377-90F55E51-65A0-459B-B796-88A6A88C8686Q34292429-F7AD6E84-4CBF-4C92-865E-CA399429B48FQ34576374-2CF47305-C6A7-4239-B230-E5DB581D808EQ34623166-729BFC6E-23DF-4507-9250-62A912BFD2CBQ34957940-7E6E2683-C470-4607-ADBF-E3A1442D9BD2Q35157954-15CA7F1C-D76C-4D52-827E-B716571ACD16Q35178803-B5AEDCB0-E58E-4412-955C-8737013FA2D9Q35612784-7F2939F8-3252-48B7-ABED-C662A7E093B6Q37232678-E0DB4E36-FBDD-4C28-82E9-FF0B30465F31Q37336200-382C969F-CF34-4D66-98E1-75549548CC57Q37473701-42E48A82-C963-4F1F-873B-2518BA1D50D4Q39420555-B2A14C70-4B1E-4B3C-A29A-F0D472B46081Q39644042-0909EE54-1B55-438D-95DF-53849883183BQ39734720-34320356-9A29-49DB-AE67-37CCBFD7FD12Q39886593-F2D96F5D-60DC-4C72-9F30-C80A76A338D3Q40270389-CF96BAD6-79B9-442E-8CDA-C51C6E4F184FQ40943241-E4F92510-BF9E-415C-A736-9668AE72C031Q41206503-C15302AC-6DB3-4A15-A15E-9DA3D52205F4Q41716386-CEB7F395-62AF-48A3-9659-27594076B427Q42092449-CED297E4-D2F9-41EB-9945-5269F99961BEQ43718269-CA9CDC2B-DF68-4862-8881-06E55D1CB6E1Q46936808-4FA98A8D-150A-4736-8385-F33AC23CAF5DQ51550714-4CC87537-9176-40FA-96E6-2F16DE1EFF6A
P2860
Reduction of glycosylated hemoglobin and postprandial hyperglycemia by acarbose in patients with NIDDM. A placebo-controlled dose-comparison study.
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Reduction of glycosylated hemo ...... trolled dose-comparison study.
@ast
Reduction of glycosylated hemo ...... trolled dose-comparison study.
@en
type
label
Reduction of glycosylated hemo ...... trolled dose-comparison study.
@ast
Reduction of glycosylated hemo ...... trolled dose-comparison study.
@en
prefLabel
Reduction of glycosylated hemo ...... trolled dose-comparison study.
@ast
Reduction of glycosylated hemo ...... trolled dose-comparison study.
@en
P2093
P921
P356
P1433
P1476
Reduction of glycosylated hemo ...... trolled dose-comparison study.
@en
P2093
Beisswenger P
Kleinfield R
Shapiro JA
P304
P356
10.2337/DIACARE.18.6.817
P407
P577
1995-06-01T00:00:00Z